Grants per year
Search results
-
Active
Prot #TCD601B203: A 12-Month, Randomized, Open-Label, Phase IIA Study Evaluating the Safety and Efficacy of Siplizumab in Combination with Belatacept and MPA Compared to Standard of Care Immunosuppression in de novo Renal Transplant Recipients (ASCEND)
Leventhal, J. R. (PD/PI)
2/21/24 → 2/21/27
Project: Research project
-
The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation
Tambur, A. R. (PD/PI), Forte, E. (Co-Investigator), Forte, E. (Co-Investigator), Kelleher, N. L. (Co-Investigator), Leventhal, J. R. (Co-Investigator) & Thorp, E. B. (Co-Investigator)
National Institute of Allergy and Infectious Diseases
8/17/23 → 7/31/27
Project: Research project
-
Improving the Lives of Transplant Patients: Devising a Method to Stop Long-Term Immunosuppressive Drug Treatment After Transplantation
Leventhal, J. R. (PD/PI), Mathew, J. (Co-PD/PI), Sambandam, Y. (Co-Investigator) & Zhu, F. (Co-Investigator)
Northwestern Memorial Hospital
9/1/21 → 8/31/25
Project: Research project
-
Regenerative Engineering Training Program (RE-Training)
Ameer, G. A. (PD/PI), Ameer, G. A. (PD/PI), Leventhal, J. R. (Other) & Leventhal, J. R. (Other)
National Institute of Biomedical Imaging and Bioengineering
9/1/21 → 8/31/26
Project: Research project
-
Informing Ethical Translation of Xenotransplantation Clinical Trials
Gordon, E. (PD/PI), Leventhal, J. R. (PD/PI), Leventhal, J. R. (PD/PI) & Leventhal, J. R. (PD/PI)
Hastings Center Inc., National Center for Advancing Translational Sciences
8/9/21 → 7/31/25
Project: Research project
-
Protocol FCR001A2301 - A Randomized, Controlled, Multi-center, Safety and Efficacy Study of FCR001 Cell-Based Therapy Relative to a Tacrolimus and Mycophenolate-Based Regimen in De Novo Living Donor Renal Transplant Recipients, and Safety in FCR001 Donors
Leventhal, J. R. (PD/PI)
CTI Clinical Trial and Consulting Services, ImmunoFree, Inc.
10/2/19 → 10/2/25
Project: Research project
-
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Leventhal, J. R. (PD/PI) & Mathew, J. (Co-Investigator)
Regenerex LLC, Novartis Pharmaceuticals Corporation
7/1/14 → 8/31/25
Project: Research project
-
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor Stem Cell Infusion
Leventhal, J. R. (PD/PI) & Mathew, J. (Co-Investigator)
Regenerex LLC, Novartis Pharmaceuticals Corporation
7/1/14 → 8/31/25
Project: Research project